Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer-controlled in-vitro simulation of multiple dosing regimens.

B Ledergerber, J Blaser, R Lüthy

    The Journal of Antimicrobial Chemotherapy
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2023
    Same author

    Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding.

    Digestive diseases and sciences·2021
    Same author

    Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.

    HIV medicine·2021
    Same author

    Hyperglycaemia and pharmacokinetics of rifampicin/isoniazid among TB-HIV co-infected patients in Kampala, Uganda.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
    Same author

    The EuroSIDA study: 25 years of scientific achievements.

    HIV medicine·2019
    Same author

    Home-based color card screening for biliary atresia: the first steps for implementation of a nationwide newborn screening in Germany.

    Pediatric surgery international·2019
    Same journal

    Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Re-evaluating the 14-day rule: short-course antifungal therapy for uncomplicated candidaemia in a multicentre cohort study.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Impact of selective digestive decontamination on the pangenome composition of ESBL-E. coli.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Compounds of the γ-carboline family inhibit trans-translation.

    The Journal of antimicrobial chemotherapy·2026
    See all related articles

    Gentamicin effectively reduced Pseudomonas aeruginosa counts when administered in a high peak concentration, low frequency dosing regimen. Lower peak concentrations with more frequent dosing were less effective in this in-vitro study.

    Area of Science:

    • Pharmacology
    • Microbiology
    • In-vitro modeling

    Background:

    • Pseudomonas aeruginosa is an opportunistic pathogen requiring effective antimicrobial strategies.
    • Optimizing gentamicin dosing is crucial for maximizing efficacy and minimizing resistance.
    • Dynamic in-vitro models offer a platform for simulating complex dosing regimens.

    Purpose of the Study:

    • To investigate the bactericidal effect of gentamicin against Pseudomonas aeruginosa ATCC 27853.
    • To compare the efficacy of three different gentamicin dosing regimens in a dynamic in-vitro model.
    • To evaluate the role of microcomputer-controlled models in antimicrobial studies.

    Main Methods:

    • Utilized a computer-controlled dynamic in-vitro model to simulate gentamicin dosing.

    Related Experiment Videos

  • Tested three regimens: 32 mg/l every 32 h, 16 mg/l every 16 h, and 8 mg/l every 8 h.
  • Monitored colony-forming unit (cfu) counts over several days.

    • Main Results:

    • The regimen of 32 mg/l every 32 h demonstrated the most effective reduction in P. aeruginosa cfu-counts.
    • Lower peak concentrations (16 mg/l every 16 h and 8 mg/l every 8 h) were significantly less effective after the second dose.
    • Microcomputer control facilitated in-vitro dosing regimen simulation.

    Conclusions:

    • High peak concentration, low frequency gentamicin dosing is superior for reducing P. aeruginosa in this in-vitro model.
    • Turbidity measurements are insufficient for assessing rapid bactericidal effects.
    • Dynamic in-vitro models are valuable tools for optimizing antimicrobial dosing strategies.